Treatment of Stargardt disease with dobesilate.
作者信息
Cuevas Pedro, Outeiriño Luis A, Angulo Javier, Giménez-Gallego Guillermo
机构信息
Departamento de Investigación, IRYCIS, Hospital Universitario Ramón y Cajal, Madrid, Spain.
出版信息
BMJ Case Rep. 2012 Oct 12;2012:bcr2012007128. doi: 10.1136/bcr-2012-007128.
Abstract
Stargardt disease is a common inherited macular degeneration characterised by a significant loss in the central vision during the first or second decade of the life. Bilateral atrophic changes in the central retina are associated with degeneration of photoreceptors and underlying retinal pigment epithelium, and yellow flecks are extending from the macula. We present a patient with Stargardt disease treated with an intravitreal injection of dobesilate, showing an improvement of visual acuity 4 weeks after treatment.
摘要
相似文献
1
Treatment of Stargardt disease with dobesilate.
BMJ Case Rep. 2012 Oct 12;2012:bcr2012007128. doi: 10.1136/bcr-2012-007128.
2
Intravitreal dobesilate in the treatment of choroidal neovascularisation associated with age-related macular degeneration: report of two cases.
BMJ Case Rep. 2012 Sep 3;2012:bcr2012006619. doi: 10.1136/bcr-2012-006619.
3
Durable recovery of the macular architecture and functionality of a diagnosed age-related macular degeneration 1 year after a single intravitreal injection of dobesilate.
BMJ Case Rep. 2013 Nov 13;2013:bcr2013010203. doi: 10.1136/bcr-2013-010203.
4
Treatment of dry age-related macular degeneration with dobesilate.
BMJ Case Rep. 2012 Jun 21;2012:bcr0220125942. doi: 10.1136/bcr.02.2012.5942.
5
Defective lipid transport and biosynthesis in recessive and dominant Stargardt macular degeneration.
Prog Lipid Res. 2010 Oct;49(4):476-92. doi: 10.1016/j.plipres.2010.07.002. Epub 2010 Jul 13.
6
Dobesilate in the treatment of plaque psoriasis.
Eur J Med Res. 2005 Sep 12;10(9):373-6.
7
Chronic cystoid macular oedema treated with intravitreal dobesilate.
BMJ Case Rep. 2012 Jul 9;2012:bcr2012006376. doi: 10.1136/bcr-2012-006376.
8
Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy.
Eur J Med Res. 2012 Jul 12;17(1):22. doi: 10.1186/2047-783X-17-22.
9
Early-onset stargardt disease: phenotypic and genotypic characteristics.
Ophthalmology. 2015 Feb;122(2):335-44. doi: 10.1016/j.ophtha.2014.08.032. Epub 2014 Oct 17.
10
Novel therapeutics for Stargardt disease.
Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1057-1062. doi: 10.1007/s00417-017-3619-8. Epub 2017 Mar 11.
引用本文的文献
1
Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease.
Mol Ther Nucleic Acids. 2019 Sep 6;17:819-828. doi: 10.1016/j.omtn.2019.07.018. Epub 2019 Aug 1.
2
Diacetyloxyl derivatization of the fibroblast growth factor inhibitor dobesilate enhances its anti-inflammatory, anti-angiogenic and anti-tumoral activities.
J Transl Med. 2015 Feb 1;13:48. doi: 10.1186/s12967-015-0413-4.
本文引用的文献
1
Intravitreal dobesilate in the treatment of choroidal neovascularisation associated with age-related macular degeneration: report of two cases.
BMJ Case Rep. 2012 Sep 3;2012:bcr2012006619. doi: 10.1136/bcr-2012-006619.
2
Transport of fibroblast growth factor 2 in the pericellular matrix is controlled by the spatial distribution of its binding sites in heparan sulfate.
PLoS Biol. 2012 Jul;10(7):e1001361. doi: 10.1371/journal.pbio.1001361. Epub 2012 Jul 17.
3
Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy.
Eur J Med Res. 2012 Jul 12;17(1):22. doi: 10.1186/2047-783X-17-22.
4
Chronic cystoid macular oedema treated with intravitreal dobesilate.
BMJ Case Rep. 2012 Jul 9;2012:bcr2012006376. doi: 10.1136/bcr-2012-006376.
5
Treatment of dry age-related macular degeneration with dobesilate.
BMJ Case Rep. 2012 Jun 21;2012:bcr0220125942. doi: 10.1136/bcr.02.2012.5942.
6
Inflammasomes in health and disease.
Nature. 2012 Jan 18;481(7381):278-86. doi: 10.1038/nature10759.
7
The expanding role of vascular endothelial growth factor inhibitors in ophthalmology.
Mayo Clin Proc. 2012 Jan;87(1):77-88. doi: 10.1016/j.mayocp.2011.10.001.
8
Differential gene expression in eyecup and retina of a mouse model of Stargardt-like macular dystrophy (STGD3).
Invest Ophthalmol Vis Sci. 2012 Feb 13;53(2):664-75. doi: 10.1167/iovs.11-8418.
9
Centrifugal expansion of fundus autofluorescence patterns in Stargardt disease over time.
Arch Ophthalmol. 2012 Feb;130(2):171-9. doi: 10.1001/archophthalmol.2011.332. Epub 2011 Oct 10.
10
Complement system dysregulation and inflammation in the retinal pigment epithelium of a mouse model for Stargardt macular degeneration.
J Biol Chem. 2011 May 27;286(21):18593-601. doi: 10.1074/jbc.M110.191866. Epub 2011 Apr 4.
Zotero 插件